Clover Biopharmaceuticals Ltd.'s total assets for Q4 2025 were ¥458.12M, a decrease of -22.90% from the previous quarter. HK:2197 total liabilities were ¥2.26B for the fiscal quarter, a -1.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.